Jennifer Massey

Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial

Graeme J. Hankey, Maree L. Hackett, Osvaldo P. Almeida et al. · The Lancet Neurology · 2020 · 145 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis

John J. Moore, Jennifer Massey, Carole Ford et al. · Journal of Neurology Neurosurgery & Psychiatry · 2018 · 96 citations · Full text

Medicine, Hematology, Immunology +14

Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis

Izanne Roos, Stella Hughes, Gavin McDonnell et al. · JAMA Neurology · 2023 · 60 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +15

Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis

Tomáš Kalinčík, Sifat Sharmin, Izanne Roos et al. · JAMA Neurology · 2023 · 52 citations · Full text

Medicine, Neurology, Pharmacotherapy +13

Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis

Jannis Müller, Sifat Sharmin, Johannes Lorscheider et al. · JAMA Neurology · 2025 · 42 citations · Full text

Medicine, Neurology, Disability Management +7